Enzyme-Enabled Cold-Brew Concentrates Market is set to grow from USD 1.21 Billion in 2025 to USD 3.27 Billion by 2036, with a CAGR of 10.4%. Amylase-based formulations is poised to dominate the enzyme type segment with a 36.0% share, while Liquid concentrates is expected to lead the concentrate format category at 55.0%.